Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 2491 AL 2505

Suspecting Non-Alzheimer's Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images

Malotaux V, Colmant L, Quenon L, Huyghe L, Gérard T, Dricot L, Ivanoiu A, Lhommel R, Hanseeuw B.

J Alzheimers Dis. 2024;97(1):421-433. doi: 10.3233/JAD-230696.

Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial

Brum WS, Docherty KF, Ashton NJ, Zetterberg H, Hansson O, McMurray JJV, Blennow K.

JAMA Neurol. 2024 Feb 1;81(2):197-200. doi: 10.1001/jamaneurol.2023.4719.

Investigating Sex Differences in Risk and Protective Factors in the Progression of Mild Cognitive Impairment to Dementia: A Systematic Review

Martin J, Reid N, Ward DD, King S, Hubbard RE, Gordon EH.

J Alzheimers Dis. 2024;97(1):101-119. doi: 10.3233/JAD-230700.

Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease

Lojo-Ramírez JA, Guerra-Gómez M, Marín-Cabañas AM, Fernández-Rodríguez P, Bernal Sánchez-Arjona M, Franco-Macías E, García-Solís D.

J Alzheimers Dis. 2024;97(1):447-458. doi: 10.3233/JAD-230744.

Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer's Disease Continuum: A Retrospective Observational Study

Ricci F, Martorana A, Bonomi CG, Serafini C, Mercuri NB, Koch G, Motta C.

J Alzheimers Dis. 2024;97(2):599-607. doi: 10.3233/JAD-230792.

Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease

Weinberg MS, He Y, Kivisäkk P, Arnold SE, Das S.

J Alzheimers Dis. 2024;99(s2):S355-S365. doi: 10.3233/JAD-230899.

Navigating the dementia landscape: Biomarkers and emerging therapies

Maheshwari S, Singh A, Ansari VA, Mahmood T, Wasim R, Akhtar J, Verma A.

Ageing Res Rev. 2024 Feb;94:102193. doi: 10.1016/j.arr.2024.102193. Epub 2024 Jan 10.

Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

Hayek D, Ziegler G, Kleineidam L, Brosseron F, Nemali A, Vockert N, Ravichandran KA, Betts MJ, Peters O, Schneider LS, Wang X, Priller J, Altenstein S, Schneider A, Fliessbach K, Wiltfang J, Bartels C, Rostamzadeh A, Glanz W, Buerger K, Janowitz D, Perneczky R, Rauchmann BS, Teipel S, Kilimann I, Laske C, Mengel D, Synofzik M, Munk MH, Spottke A, Roy N, Roeske S, Kuhn E, Ramirez A, Dobisch L, Schmid M, Berger M, Wolfsgruber S, Yakupov R, Hetzer S, Dechent P, Ewers M, Scheffler K, Schott BH, Schreiber S, Orellana A, de Rojas I, Marquié M, Boada M, Sotolongo O, González PG, Puerta R, Düzel E, Jessen F, Wagner M, Ruiz A, Heneka MT, Maass A.

Mol Psychiatry. 2024 Apr;29(4):992-1004. doi: 10.1038/s41380-023-02387-3. Epub 2024 Jan 12.

Degeneration of the cholinergic system in individuals with subjective cognitive decline: A systematic review

Rodriguez-Hernandez MA, Alemany I, Olofsson JK, Diaz-Galvan P, Nemy M, Westman E, Barroso J, Ferreira D, Cedres N.

Neurosci Biobehav Rev. 2024 Feb;157:105534. doi: 10.1016/j.neubiorev.2024.105534. Epub 2024 Jan 14.

Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology

Kobayashi R, Morioka D, Kawakatsu S, Sakamoto K, Suzuki A.

Alzheimer Dis Assoc Disord. 2024 Jan-Mar 01;38(1):95-97. doi: 10.1097/WAD.0000000000000597. Epub 2024 Jan 17.

Monitoring synaptic pathology in Alzheimer's disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives

Lista S, Santos-Lozano A, Emanuele E, Mercuri NB, Gabelle A, López-Ortiz S, Martín-Hernández J, Maisto N, Imbimbo C, Caraci F, Imbimbo BP, Zetterberg H, Nisticò R.

Mol Psychiatry. 2024 Mar;29(3):847-857. doi: 10.1038/s41380-023-02376-6. Epub 2024 Jan 16.

The Room Where It Happens: Clinician Reflections on Returning Preclinical Alzheimer's Biomarker Results to Research Participants

Erickson CM, Chin NA, Ketchum FB, Eveler ML, Conway CE, Coughlin DM, Clark LR.

J Prev Alzheimers Dis. 2024;11(1):1-6. doi: 10.14283/jpad.2023.88.

Phase 1/2a Intravenous and Subcutaneous Oligomer-Specific Antibody KHK6640 in Mild to Moderate Alzheimer's Disease

Cantillon M, Andreasen N, Prins N.

J Prev Alzheimers Dis. 2024;11(1):65-70. doi: 10.14283/jpad.2024.2.

Digital Clock Drawing as an Alzheimer's Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults

Thompson LI, Cummings M, Emrani S, Libon DJ, Ang A, Karjadi C, Au R, Liu C.

J Prev Alzheimers Dis. 2024;11(1):79-87. doi: 10.14283/jpad.2023.48.

Alzheimer's Disease Biomarker Analysis Using Targeted Mass Spectrometry

Gobom J, Brinkmalm A, Brinkmalm G, Blennow K, Zetterberg H.

Mol Cell Proteomics. 2024 Feb;23(2):100721. doi: 10.1016/j.mcpro.2024.100721. Epub 2024 Jan 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias